Litcius/Paper detail

Discordance between Immunohistochemistry and Erb-B2 Receptor Tyrosine Kinase 2 mRNA to Determine Human Epidermal Growth Factor Receptor 2 Low Status for Breast Cancer

Keying Xu, Jane Bayani, Elizabeth Mallon, Gregory R. Pond, Tammy Piper, Annette Hasenburg, Christos Markopoulos, Luc Dirix, Caroline Seynaeve, Cornelis J.�H. van de Velde, Daniel Rea, John M.S. Bartlett

2022Journal of Molecular Diagnostics31 citationsDOIOpen Access PDF

Topics & Concepts

ImmunohistochemistryBreast cancerEpidermal growth factor receptorTyrosine kinaseCancer researchReceptor tyrosine kinaseHuman Epidermal Growth Factor Receptor 2ReceptorInternal medicineBiologyOncologyMedicineCancerHER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchColorectal Cancer Treatments and Studies
Discordance between Immunohistochemistry and Erb-B2 Receptor Tyrosine Kinase 2 mRNA to Determine Human Epidermal Growth Factor Receptor 2 Low Status for Breast Cancer | Litcius